We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Immunity to COVID-19 Higher Than Serological Tests Suggest

By HospiMedica International staff writers
Posted on 06 Jul 2020
Print article
A new study shows that many people with mild or asymptomatic COVID-19 demonstrate a T-cell-mediated immunity, even if they have not tested positively for antibodies.

For the study, researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (KUH; Stockholm, Sweden) performed immunological analyses of samples from over 200 inpatients (many of whom had mild or no symptoms of COVID-19) at KUH, as well as their exposed asymptomatic family members who returned to Stockholm after holidaying in the Alps in March 2020. Healthy blood donors who gave blood during 2020 and 2019 (the control group) were also included.

The researchers then mapped the functional and phenotypic landscape of T-cell responses. They found that SARS-CoV-2-specific T cells were detectable in seronegative family members and individuals with a history of asymptomatic or mild COVID-19. The collective dataset showed that SARS-CoV-2 elicits robust memory T cell responses, akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 in seronegative individuals as well. The study was published on June 29, 2020, in in bioRxiv.

“T cells are a type of white blood cells that are specialized in recognizing virus-infected cells, and are an essential part of the immune system. Advanced analyses have now enabled us to map in detail the T-cell response during and after a COVID-19 infection,” said senior author Marcus Buggert, PhD, of KI. “Our results indicate that roughly twice as many people have developed T-cell immunity compared with those who we can detect antibodies in.”

“One interesting observation was that it wasn't just individuals with verified COVID-19 who showed T-cell immunity, but also many of their exposed asymptomatic family members,” said study co-author Soo Aleman, PhD, of KUH. “Moreover, roughly thirty percent of the blood donors who'd given blood in May 2020 had COVID-19-specific T cells, a figure that's much higher than previous antibody tests have shown.”

T cells are lymphocytes that originate in the bone marrow and mature in the thymus. They determine the specificity of immune response to antigens. They can be distinguished from other lymphocytes by the presence of a T-cell receptor on the cell surface. One of the more important T-cells are CD4+ helper cells which send signals to other types of immune cells, including CD8 killer cells, which then destroy the infectious particle.

Related Links:
Karolinska Institutet
Karolinska University Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.